Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERIT: Multihance vs Gadovist in Brain MRI
NCT00907530Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Sep 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gadobenate dimeglumine in brain tumor, sponsored by Bracco Diagnostics Inc.. Started Sep 2009; status: completed.
02
Drugs
gadobenate dimeglumine
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT00907530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907530.